Gait Trainer Market is expected to witness a CAGR of 4.9% from 2021 to 2028

The global market for gait trainers is being progressively influenced by the growing competition and the expansion of the walking aids industry. The rising number of spinal injuries as well as strokes that impacts the ability of a patient to walk has been incessantly supporting the global gait trainer market to grow and has been expected to remain the same in the forthcoming years. In Europe and North America, manufacturers are strengthening their position as they are the key focus regions with the maximum potential for the players to take leverage from. For instance, key players such as Rifton Equipment, Ottobock Inc.., Ekso Bionics, Hocoma AG, and AlterG are expanding their commercial presence in international market.

The players in the market are increasingly focusing on raising their market penetration through exploration of the untapped markets. In order to increase its market penetration, the company is focusing on enhancement of its products by introducing new technologies and upgrading its existing products and also simultaneously focusing on strategic alliances for sale and promotion of its products globally. Manufacturers are basically focusing on upscaling the production of automated gait trainer.

To remain ‘ahead’ of your competitors, request for a sample

The proliferating acquisition activities and contractual agreements between manufacturers and local service providers are the factors promoting the growth of the global gait trainer market. Manufacturers of gait trainer devices and exoskeletons are focusing on government contracts and agreements with other medical device companies, in order to manufacture cost-effective products, especially for rehabilitation.

According to the report published by Future Market Insights (FMI), the global gait trainer market is expected to witness a CAGR of 4.9% from 2022 to 2028. In 2017, the market was worth US$ 271.5 Mn and is projected to rise to a valuation of US$ 456.3 Mn by the end of 2028.

Prominent Players:

Meyland Smith A/S

Biodex Medical Systems

medica Medizintechnik GmbH

ReWalk Robotics

Alter G Inc.

Rex Bionics Ltd.

Ekso Bionics

Hocoma AG

Otto Bock Inc.

Rifton Equipment

Medical Depot Inc. (Drive Medical)

Pricing Available upon Request

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-2213

Gait Trainer Market COVID-19 Crisis Impact

The COVID-19 pandemic of 2020 revolutionized the healthcare industry in a way that was never expected and generated a general sense of health awareness across the globe which was a trend that was shaping up over the past few years.

Focus on healthcare has grown exponentially especially in the COVID-19 pandemic and this is expected to propel the demand for healthcare services and products.

The pandemic affected the healthcare industry largely and in 2020 and created a surge of demand for many medical products. The pandemic adversely affected the gait trainer industry as the sales saw a drop due to disruptions to the manufacturing and supply aspects of the business.

Consumption of gait trainers is expected to gain impetus in the post-pandemic era as government initiatives increase awareness and promote adoption of gait training equipment.

Technological Advancements to Pave Way for Market Progression

In the last couple of years, various types of gait trainers to support ambulation practices have been developed, the treadmill and over ground systems are the ones gaining popularity. Advanced gait trainer systems are predominantly designed to minimize stress–strain shielding with adjustability in height, and increase the range of motion with high efficiency. As indicated by the expert analyst, New FDA-cleared EksoGT exoskeleton comes with a controller, inbuilt software coupled with smart assist pre-gait and freegait quick fit technology. Ekso pulse comes with a cloud-based technology, analytics, wireless transmission and cloud storage.

Competitive Pricing to Obstruct Growth Tract

The price elasticity of the gait trainer market has grown extensively owing to the significant role played by the government and managed care groups. HME dealers purchase gait trainer products based primarily on the price, so that they can be assured of being reimbursed. Thereby, manufacturers must fiercely compete on price in order to win large dealer contracts and purchases. The rising Asian imports of gait trainer are bound to send the prices to a certain low. With increasing number of participants, the prices will continue to decline.

Key Segments Covered in Gait Trainer Industry Survey

Gait Trainer Market by Product Type:

Gait Trainer Walkers

Adult

Pediatric

Exoskeletons

Treadmill Systems

Gait Trainer Market by End User:

Gait Trainers for Hospitals

Gait Trainers for Rehabilitation Centers

Gait Trainers for Home Care Settings

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-2213

Gait Trainer Market by Region:

North America Gait Trainer Market

Latin America Gait Trainer Market

Europe Gait Trainer Market

East Asia Gait Trainer Market

South Asia & Pacific Gait Trainer Market

Middle East & Africa (MEA) Gait Trainer Market

Ultrasound Systems Market Exhibiting 5.7% CAGR and estimated to surpass US$ 12,500 Billion by 2021-2028

Digitization in the healthcare sector has revamped the ultrasound systems market. The advancements in different spheres of the industry has benefited not just the patients but the market too, as the demand for medical examination has surged over the past decade. A new market research report by Future Market Insights, revolves around an in-depth and an all-inclusive analysis of Global Ultrasound Systems Market, reveals a strong growth of the market due to upgraded services provided to the patients and also the easier approach to the internal body examination witnessed with the usage of ultrasound systems. According to the outcomes of global forecast mentioned in the report titled ‘Ultrasound Systems Market – Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028’, the global ultrasound systems market is expected to reach a market value of over US$ 12,500 Mn by the end of 2028, growing at an impressive CAGR of 5.7% during the forecast period.

Hospitals to hold largest share in Ultrasound Systems Market with highest demand for application in Radiology

Hospitals shift toward more value-oriented products, they need to operate more efficiently and productively. Similarly, a quality shift has occurred with patients, who more proactively involved in their care. Trends from the shift to value-based care include data integration and population health management. An influx of data combined with advancements in imaging helps leverage these data to not only bring further value but also apply it to broader populations. Along with the clearer and high definition pictures that are a part of ultrasound systems, there has also been an introduction to the portable machines. These are the more handy and easy to move form of ultrasound systems that have come into existence not long ago. Although the developed nations are already familiar with the technology, the market may find a higher prospects of growth in the developing regions. The market analysis has shown that hospitals hold the highest market share in the Global Ultrasound Systems Market, however diagnostics imaging and surgical centers are expected to raise a higher demand for the systems in the coming years. In terms of application the market is also dominated by Radiology as the key application area for ultrasound systems and is expected to continue growing further at a CAGR of 6.3% during the forecast period, as analyzed by FMI.

To remain ‘ahead’ of your competitors, request for a sample

Favourable Government Policies to Benefit Start-up Companies and Independent diagnostic centers

As a move to encourage start-up companies, government of various regions like Asia Pacific and MEA have bolstered the initiatives to support the new start-ups who are entering the healthcare and medical device industry. It includes exemption of taxes for the first three years, subsidizing patent protection cost etc. The move is intended to boost the overall market for medical devices. Specifically the medical imaging market has also taken an independent position in the global market. With the betterment in services and advanced facilities related to ultrasound or any other imaging techniques, the global market is expected to witness a higher volume of independent imaging centers. The companies have also independently introduced handy and user-friendly devices in the market. GE, Philips, Samsung, Fukuda, Mindray, Hitachi, Toshiba, and Siemens, all these companies offer their own particular models.

The coming years will showcase more advanced ultrasound systems, which will provide an image clearer than 3D or 4D pictures.

Mobile connected visualization is also an integration in the Ultrasound Systems market

Most of the machines in the healthcare industry are worked upon to integrate Artificial Intelligence. This has opened the new horizons of the health care and health related services. The technology is already a part of ultrasound machines, which now provides a 2D-3D image of the examination too. These machines are being made compact and easy to use to reduce the effort required, just like any other medical examination machine.

The hand-held or compact form of ultrasound systems are now integrated with the mobile connectivity. It is the technology allowing wireless connectivity with mobile or tablet for visualization in real-time diagnosis. This technologically advanced device also contributes in reducing queuing time alone with along with real-time monitoring in point-of-care facilities.

The trends are expected to completely abolish the use of traditional systems, as the new ones offer much more convenience to the users. Most of the end users are now preferring the use of portable systems which are equipped with many more features that provide better results.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6695

Market Taxonomy

By Modality

  • Cart/Trolley Based
  • Compact/Handheld Ultrasound Devices

By Application

  • Radiology
  • Obstetrics and Gynecology
  • Gastroenterology
  • Cardiovascular
  • Others (Breast Imaging, Urology, Emergency Care and among others)

By End User

  • Hospitals & Clinics
  • Diagnostic Imaging & Surgical Centers
  • ASCs
  • Others

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

For in-depth competitive analysis Buy Now – https://www.futuremarketinsights.com/checkout/6695

Laparoscopic Devices Market 2021 by Applications, Key Players, Products Type, Application Types and Production Information Analysis and Forecast 2029

The global laparoscopic devices market is projected to experience significant growth during the next decade (2019 – 2029), on the back of rapid growth in demand for minimally invasive surgery and expanding application potential in colorectal and bariatric surgical procedures. By the end of 2019, global sales of laparoscopic devices accounted for revenues of over US$ 10 Bn. Increasing FDI influx in developing regions coupled with marketing and promotional activities are expected to boost the laparoscopic devices market over the following years, says the report.

Key Takeaways – Laparoscopic Devices Market Study

  • Steady demand growth is observed for bariatric surgery, in line with the expanding obese population coupled with wide-scale adoption rate of minimally invasive techniques. Sales of laparoscopic devices for bariatric surgery will surpassing that for colorectal surgery towards the end of projection period.
  • Sales of laparoscopic devices will be higher in North American countries. The availability of skilled surgeons and several advantages of minimally invasive surgery over open surgery are few factors driving the market of laparoscopy devices.
  • The key players in the laparoscopic devices market are focusing on technologically advanced surgical systems with improved dexterity, ergonomics, and visual enhancements that provide advantages to surgeons and minimize the risk for patients while undergoing laparoscopic procedures.
  • Increasing consumer base along with modern amenities in the healthcare sector is expected to drive sales of laparoscopic devices in developing regions.

Rising private and foreign investments in the laparoscopic devices market and adoption of subscription commerce marketing model by market players are anticipated to shape the overall laparoscopic devices market.

To remain ‘ahead’ of your competitors, request for a sample

Growing Popularity of Single-incision Laparoscopic Surgery

Single-site incisional surgery is being widely used in laparoscopic procedures and is replacing traditional method of laparoscopic procedures, in which four to five small incisions were made as the entry point for laparoscopic instruments. Some of the key benefits of single-site incision laparoscopic procedure over traditional procedure are low chances of infections, better cosmetic results, quick recovery and less post-operative pain.

According to Journal of the Society of Laparoendoscopic Surgeons (JSLS), women who undergo single-site incision laparoscopic surgery tend to report lesser post-operative pain compared to traditional method laparoscopic surgery. Growing demand for single-incision laparoscopic surgeries would thus drive the growth of laparoscopic devices market.

Adoption of Subscription Commerce Marketing Model

Companies are adopting various marketing model schemes such as subscription commerce to boost the sale of laparoscopic devices. Under this scheme, companies provide medical devices such as laparoscopy devices on pay-per-use basis. Thus, various end use segments can have access to these devices which might otherwise be prohibitively expensive, which in turn is helping manufacturers to expand their market share for laparoscopic devices, globally.

Due to intense competition, manufacturers of laparoscopic devices use innovative pricing strategies to remain at the forefront. Expanding access of laparoscopic devices by educating healthcare professionals through various conferences and training is enabling companies manufacturing these devices to enhance the adoption and equipping healthcare facilities with the necessary tools to provide optimal care to patients.

Interested in More About Report Inclusions?

Laparoscopic Devices Market, a new study from Future Market Insights, opines on the evolution of the laparoscopic devices market from 2014 – 2018 and presents demand projections from 2019 – 2029 on the basis of product type (direct energy system devices, trocars/access device, internal closure devices, laparoscopes, hand access instruments, insufflation devices, and robotic assisted surgical system), therapeutic application (bariatric surgery, colorectal surgery, general surgery, gynecological surgery and urological surgery), and end user (hospitals, ambulatory surgical centers, and clinics) across seven major regions.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-497

LAPAROSCOPIC DEVICES MARKET TAXONOMY

The global laparoscopic devices market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product

  • Direct Energy System Devices
  • Trocars/Access Devices
  • Internal Closure Devices
  • Laparoscopes
  • Hand Access Instruments
  • Insufflation Devices
  • Robotic Assisted Surgical System

Therapeutic Application

  • Bariatric Surgery
  • Colorectal Surgery
  • General Surgery
  • Gynecological Surgery
  • Urological Surgery

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-497

Regions

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • Middle East and Africa (MEA)

Varicella Zoster Infection Treatment Market expected to register a 4.2% CAGR by the end of 2027

Future Market Insights (FMI) has published a new report on the varicella zoster infection treatment market titled “Varicella Zoster Infection Treatment Market: Global Industry Analysis 2017 – 2021 and Opportunity Assessment 2022 – 2028.” Varicella zoster infection comprises two main types namely varicella chickenpox and herpes zoster. Varicella is a highly contagious infection with an incubation period of 10–21 days, most commonly 14–16 days, after which characteristic rashes appear.

Acute varicella may be complicated by secondary bacterial skin infections, cerebellitis, encephalitis, haemorrhagic complications, and viral and bacterial pneumonia. The climate is a core factor that seems to have an impact on the epidemiology of varicella. In most of the temperate climatic regions, 90% of the people are infected before adolescence. In tropical climates, VZV infection occurs later in life and adults are more susceptible to it than children.

On the other hand, herpes zoster or shingles is a sporadic disease that is caused by the reactivation of latent VZV in the sensory nerve ganglia. It is usually self-limiting and is categorised by severe pain with dermatomal distribution and at times followed by post-herpetic neuralgia that can be chronic and debilitating among the geriatric population. Though herpes zoster can occur at any age, most of the cases are reported after the age of 50 along with increasing risks of complications.

In order to cater to the needs of the patients and provide a potential treatment for this infection, companies are entering into strategic partnerships in order to make use of the technology of the other leading companies and are also focussing on research and development.

To remain ‘ahead’ of your competitors, request for a sample 

For instance, in December 2016, Slayback and Sandoz signed an agreement with Novartis AG for the sale and marketing rights of Slayback Generic Zovirax Ointment (Acyclovir Ointment). Per the agreement Novartis obtained the sales and marketing rights, which increased their position in the market. Other leading companies operating in the market are

  • Valeant Pharmaceuticals International Inc.
  • Teva Pharmaceutical Industries Ltd
  • Pfizer Inc.
  • Mylan N.V.
  • Abbott Laboratories
  • GlaxoSmithKline Plc.
  • Dr. Reddy’s Laboratories Ltd.

According to the report, the global varicella zoster infection treatment market is expected to register a 4.2% CAGR from 2017 to 2027. In 2016, the market was worth US$ 1,257.1 Mn and is expected to reach a valuation of US$ 1,969.1 Mn by the end of 2027.

Risk of Varicella in Pregnancy and the Need to Adhere to the Guidelines of Chickenpox Treatment to Bode Well for the Market

Primary infection with varicella zoster in pregnancy may cause maternal mortality or serious morbidity issues. A particular guideline issued in 2015 assesses the evidence regarding maternal and foetal risks of varicella zoster virus infection in pregnancy. The U.K. Advisory Group and Swiss and Canadian national guidelines prescribe procedures for the use of antiviral drugs in pregnancy. The U.K. Advisory Group provides guidelines for chickenpox as well.

These guidelines recommend oral acyclovir, which should be prescribed for pregnant women within 24 hours once they present the onset of the rash and if they have 20+0 weeks of gestation or beyond. Guidelines are unanimous nevertheless, in recommending that intravenous acyclovir be administered in cases of severe maternal infection. This factor along with the fact that the rate of exposure and transmission is extremely high in this infection and is a threat for pregnant women and kids, is expected to boost the growth of the varicella zoster infection treatment market.

Natural Products to Challenge Market Growth

Several people opt for other treatment options for herpes zoster and varicella. These alternative treatment options are expected to hamper the growth of the antiviral drugs market for varicella zoster infection treatment. Homeopathy, supplements, and other natural herbal medicines are used to treat herpes zoster and varicella.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6466

Varicella Zoster Infection Treatment – Market Segmentation – by Category

By Drug Type:

  • Acyclovir
  • Valacyclovir
  • Famciclovir

By Route of Administration:

  • Oral
  • Injectable
  • Topical

By Distribution Channel:

  • Hospital pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Drug Stores

Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APECJ
  • China
  • Japan
  • Middle East Africa

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6466

Rare Inflammatory Disease Treatment Market expected to growing at a CAGR of 4.4% during the forecast period of 2021-2031

With mounting instances of genetic diseases, demand for therapeutic measures have witnessed a hike, as no effective procedures exist that provide effective treatment of genetic or rare inflammatory diseases. Chromosomal changes primarily influence prevalence of these diseases. In a bid to curtail the disease prevalence, several pharmaceutical industries have been taking efforts to make advancements in relevant drugs as well as therapeutic methods. For example, new treatment options are being developed by researchers for geriatric and pediatric patients suffering from Still’s disease, which is a rare disease linked with the inflammation of joints.

Doctors are stepping up their efforts by creating awareness among the patients with regard to benefits of anti-inflammatory drugs, which have been deemed effective in the prevention and control of rare inflammatory diseases. Currently, there is rapid increase in the demand for authorized effective treatments of the rare inflammatory diseases. The OOPD (Office of Orphan Products Development) has been offering incentives to drug companies, supporting the development of treatment methods for these diseases. National Institutes of Health (NIH) are providing immense support for improving patients’ health, by focusing mainly on the development of new treatment methods. Collaborative projects are being initiated by NIH in order to examine the common causes and effects of related diseases.

Significant findings from report show that the global market for rare inflammatory disease treatment will increase at an assessed 4.4% CAGR during the forecast period, 2017-2026. The report also anticipates that by 2026-end, rare inflammatory disease treatment worth nearly US$ 15,960.8Mn will be witnessed across the globe.

Increasing Inflammatory & Autoimmune Diseases to Create Opportunities for New Therapies

Several group of scientists have associated cytokine IL-23 with treatment of inflammatory and autoimmune diseases, which in turn is creating new ways of development for therapies. Researchers have identified a fundamental molecular mechanism essential to inflammatory and autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and psoriasis. The action of pro-inflammatory cytokine IL-23, depends on the organizational stimulation of its receptor, namely IL-23R.

Moreover, the occurrence of inflammatory and autoimmune diseases is increasing on a rapid pace. Globally, an approximate number of 125 million populace are affected by psoriasis and around 100 million by rheumatoid arthritis annually. The presence of inflammatory bowel infections such as ulcerative colitis and Crohn’s disease is increasing at an alarming rate in formerly unaffected fragments of the world.

To remain ‘ahead’ of your competitors, request for a sample

Key Takeaways from Rare Inflammatory Disease Treatment Market Report for Estimated Period, 2017-2026

  • In terms of revenue, North America will remain the largest market for rare inflammatory disease treatment market, closely followed by Europe. Nearly half value share of the market is held by rare inflammatory disease treatment sales in North America and Europe collectively. APEJ will also bolt onto a largest market revenue share, by registering a relatively faster expansion than Europe in the market through 2026.
  • On the basis of indication, ulcerative colitis are likely to remain considerably larger than that of the other segments.
  • The lion’s share in the global market for rare inflammatory disease treatment is contributed by biologics segment.
  • Oral care & Hospital Pharmacies will observe fastest growth during the forecast period.

Key market players outlined by the report is inclusive of

  • Pfizer, Inc.
  • Allergan Plc
  • Valeant
  • Johnson & Johnson
  • Questcor Pharmaceuticals, Inc.
  • Novartis AG
  • Abbvie
  • Abbott Laboratories
  • Regeneron Pharmaceuticals
  • Swedish Orphan Biovitrum AB.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-6428

Market Taxonomy

For meeting the objectives of the findings, the global rare inflammatory disease treatment market report has been segmented based on the distribution channel, drug class, mode of administration, indication, and region. As per the taxonomy detailed in the report, global market for rare inflammatory diseases treatment has been listed accordingly:

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

Indication

  • Ulcerative Colitis
  • Juvenile Rheumatoid Arthritis
  • Psoriatic Arthritis
  • Other Indications

Drug Class

  • Biologics
  • Organic Compounds

Mode of Administration

  • Injectables
  • Oral
  • Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-6428

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Anti-Osteoporosis Therapy and Fracture Healing Market to progress at an impressive 5% CAGR through 2030

Osteoporosis is a condition in which an individual starts losing his or her bone mass density. The condition increases the risk of bone cracks and fractures. There are several therapeutic options including oral drugs and injectable available for the treatment of osteoporosis. According to Future Market Insights (FMI), the anti-osteoporosis therapy and fracture healing market will register continued growth between 2020 and 2030. By the end of 2021, it is expected to surpass US$ 12 Bn.

Various leading market players are focusing on collaborative product development that has led to product innovation and availability of therapeutic options. For instance, GSK Consumer Healthcare has been established under single business following the completion of the merger of the consumer arms of GSK and Pfizer on August 1 in 2020

Rapidly growing ageing populations and rising prevalence of obesity expected to create considerable growth opportunities. The anti-osteoporosis therapy and fracture healing market is expected to grow significantly in terms of revenue over the forecast period owing to the increase in the availability of technologically advanced products options all over the world.

Moreover, stringent regulations are key restraints affecting growth of anti-osteoporosis therapy and fracture healing market. Side effects caused by osteoporosis drugs such as mild to fatal nausea, skin rashes, and others could affect growth of the market. Stringent regulations imposed by international organizations such as the U.S. Food and Drug Administration, which also conducts frequent revisions of side effects for osteoporosis drugs are challenging anti-osteoporosis therapy and fracture healing market growth.

To remain ‘ahead’ of your competitors, request for a sample

Key Takeaways from Anti-osteoporosis Therapy and Fracture Healing Market Study

Anti-osteoporosis therapy and fracture healing market is expected to register 4.5% Y-o-Y growth in 2021

The demand from the U.S. is expected to be considerably, enabling it to account for a little below 90% of the North America market

The U.K. market is expected to register 5.4% Y-o-Y growth in 2021

France and Germany are likely to exhibit considerably high demand for anti-osteoporosis therapy and fracture healing

Within East Asia, both Japan and South Korea will emerge as key markets

“Increasing prevalence of osteoporosis and rising number of road accidents have fuelled the demand for minimally invasive therapeutics, which is sees as a key market driver. Market players are currently focusing on expanding their distribution channels to strengthen their footprint within the market, while hospital pharmacies continue to remain their preferred channel,” a lead FMI analyst.

Product Launches Remain Key Strategy

Product approvals by the U. S. FDA for anti-osteoporosis therapy and fracture healing drugs as well as injectable are expected to push towards high competition among market players. Numerous companies are focusing on advanced product development that is convenient to use and provide rapid efficacy in the treatment of osteoporosis.

For Instance, in April 2019, Amgen Inc. announced about approval of its EVENITY® by U.S. Food and Drug Administration (FDA) used in the treatment of postmenopausal women at high risk for fracture. According to FMI, oral drugs will continue accounting for the leading market share. Oral will remain highly preferred as route of drug administration, accounting for over 64% of the market in 2021.

Who is winning?

The global market is set to broaden its scope in the forecast period, stimulated by high prevalence rate of osteoporosis, rising geriatric population globally and adoption of advanced anti-osteoporosis therapy and fracture healing products which can be used for long term care needs. In addition to this, changing regulatory dynamics and patent expiry of blockbuster drugs has constrained the sales of anti-osteoporosis therapy and fracture healing products.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-1008

The key market players covered by FMI include

  • Eli Lilly and Company
  • Pfizer, Inc.
  • Amgen Inc.
  • Merck and Company Inc.
  • Novartis International AG
  • F. Hoffmann La Roche Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • GlaxoSmithKline Plc.

consolidating their positions through mergers, acquisitions and new product launches.

Anti-osteoporosis Therapy and Fracture Healing Market by Category

Drug Type

  • Bisphosphonates

Osteoporosis

Others

  • Calcitonin

Osteoporosis

Others

  • Estrogen or Hormone Replacement Therapy

Osteoporosis

Others

  • Others

Osteoporosis

Others

Route of Administration

  • Oral

Osteoporosis

Others

  • Injectable
    • Osteoporosis
    • Others

Distribution Channel

  • Hospital Pharmacies

Osteoporosis

Others

  • Drug Stores

Osteoporosis

Others

  • Retail Pharmacies

Osteoporosis

Others

  • E-commerce

Osteoporosis

Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-1008

Region

North America

Latin America

Europe

South Asia

East Asia

Oceania

Middle East and Africa (MEA)

Soil Stabilization Materials Market is expected to reach close to US$ 15 Bn by the end of the forecast period 2018 – 2028

Future Market Insights presents a detailed analysis and delivers key insights on the global soil stabilization materials market in its latest report titled “Soil Stabilization Materials Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028”. The long-term outlook of the global soil stabilization materials market remains positive with the soil stabilization materials value pegged at over US$ 15.7 Bn in 2018. It is expected to reach US$ 29 Bn by the end of 2028, growing with a healthy CAGR of 6.6%. Among the segments by material type, the minerals & stabilizers segment is estimated to hold a dominant share in terms of value over the forecast period. Under the minerals & stabilizers segment, the lime sub-segment is expected to be at the forefront throughout the forecast period. However, the polymer segment is expected to grow with a relatively higher CAGR, with significant growth in value share. Among all regions, China is expected to dominate the global soil stabilization market throughout the forecast period with a healthy CAGR of 7.0%.  In this report, FMI sheds light on the drivers and restraints expected to impact the global soil stabilization materials market during the forecast period.

Get a Free Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-7428

Soil Stabilization Materials Market: Dynamics

The global soil stabilization materials market is expected to witness robust growth during the forecast period, mainly driven by the rapidly growing construction industry. Rapid population growth and escalated urbanization have boosted the building and construction industry in developing countries.  Also, the increasing demand for sustainable infrastructure and increasing need for efficient road transportation to facilitate effective global & international trade are expected to surge the soil stabilization materials market across the globe. Increasing governmental focus on infrastructural development and rising investments in real estate have surged the growth of the construction sector. Increasing infrastructural investments by governments across Asia Pacific, North America and Western Europe are expected to lead to an increase in the number of roads, railways, bridges, pathways, etc., which in turn will escalate the soil stabilization materials market. Also, the increasing need for high agricultural productivity and the rising demand for high agricultural yield are pegged to boost the demand for soil stabilization materials from the agricultural sector. Also, other end-use applications such landfilling and increasing sports activities due to the growing attention towards sports are slated to ramp up the consumption of soil stabilization materials.

Soil Stabilization Materials Market: Segmentation Analysis

The global soil stabilization materials market has been segmented on the basis of application type into industrial, non-agriculture and agriculture.

  • On the basis of application, the industrial segment is estimated to dominate the global soil stabilization materials market in terms of value over the forecast period
  • Under the industrial segment, the roads and runways sub-segment is expected hold the lion’s share in terms of value and grow with a significant CAGR of 7.2%

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-7428

Soil Stabilization Materials Market: Regional Forecast

From a regional perspective, China, North America and Western Europe are expected to collectively account for over a 70% value share in the global soil stabilization materials market. All the regions are expected to witness sound growth, except Japan, which is expected to exhibit slow growth with a CAGR below 5%.  Regions such as North America and Asia Pacific are expected to register significant growth with CAGRs above 7%. The growth of the construction industry across the globe and the launch of new governmental projects in developing and developed economies are projected to drive the demand for soil stabilization materials.

Soil Stabilization Materials Market: Competition Landscape

Some of the key players identified during the study of the global soil stabilization materials include Graymont Limited, Carmuse, Low & Bonar PLC, Tensar Corporation, Boral Limited, Adelaide Brighton Limited, Sibelco Australia Ltd., Ube Industries, Ltd., Lhoist and Thrace Group, among others.

Soil Stabilization Materials Market: Segmentation

Material Type

  • Polymers
  • Minerals & Stabilizing agents
  • Portland Cements
  • Lime
  • Fly-Ash
  • Others
  • Others
  • Agriculture Waste
  • Sludge & Slag
  • Salts

Applications

  • Industrial
  • Roads, Runways
  • Landfills
  • Non Agriculture
  • Sports
  • Residential
  • Others
  • Agriculture

Region

  • North America
  • Western Europe
  • SEA & Other APAC
  • Latin America
  • Eastern Europe
  • MEA
  • Japan
  • China

Feel free to ask your queries at https://www.futuremarketinsights.com/ask-question/rep-gb-7428

Key questions answered in the report

  • How has the soil stabilization materials market evolved in the past four years?
  • What shape will the soil stabilization materials market take in terms of volume and value during the study period?
  • What are some of the prevailing market dynamics in the soil stabilization materials market?
  • What are some of the key developments and trends in soil stabilization materials market?
  • What are some of the underlying macro-economic and industry factors impacting the growth of the soil stabilization materials market?
  • What are some of the important key challenges, opportunities and improvement factors for market players present in the soil stabilization material market?
  • What are some of the important market positioning and key strategies of key manufacturers as per the market taxonomy?
  • How the competition is structured at present and how has it evolved in the soil stabilization materials market over the past few years?

For more insights on the soil stabilization materials market, write in to Future Market Insights analysts at press@futuremarketinsights.com

 

Hexylene Glycol Market Insights, Deep Analysis of Key Vendor in the Industry Forecast to 2029

Hexylene glycol is witnessing high demand in the personal care and cosmetics industry, since it is used as a surfactant, emulsifier, and viscosity reducing agent in several products. Moreover, growing utilization of hexylene glycol as a direct solvent in paints & coatings, household and industrial cleaners, etc., is expected to pave the way for decent sales during the forecast period (2019-2029).

The global hexylene glycol market was valued at around US$ 187 Mn in 2018, with a market volume of 73,590 tons.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5703

Key Takeaways from Global Hexylene Glycol Market Study

  • Pharmaceutical and industrial-grade hexylene glycol is likely to be sought-after in the future, owing to the growth of pharma and construction industries.
  • Demand for printing inks is rapidly increasing due to rapid growth of the packaging industry. This factor will drive the growth of the hexylene glycol market, owing to its application in the formulation of printing inks.
  • Growth prospects are high in emerging markets such as India and Indonesia. Companies are focusing on different strategies in order to ensure good presence in both, emerging and matured markets. Since there are limited opportunities for hexylene glycol manufacturers in developed regions, manufacturers are focusing on emerging markets to capture a larger market share.
  • East Asia, South Asia, and North America are expected to be prominent regions over the forecast period, owing to the presence of a large number of tier II & III players in East Asia and tier I players in North America.

“Low evaporation rate and complete miscibility with water make hexylene glycol an excellent solvent. As a result, its application across several end-use industries is projected to rise, driving market growth over the forecast period.”

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5703

Hexylene Glycol Market: Competitive Landscape

The hexylene glycol market is fairly consolidated. Global players such as BASF SE, Solvay SA, Dow DuPont, and Lonza Group have invested strategically in the hexylene glycol market in the recent past, which suggests that major manufactures are keeping tabs on the market, as it holds a lot of potential in the coming future. Research & development, coupled with expansion of production capacity and footprint, remains the key strategy being followed by hexylene manufacturers to enhance productivity and capture new market opportunities.

North America Holds Noteworthy Share

North America is anticipated to hold a prominent share of the global hexylene glycol market, owing to increasing demand from the paints & coatings industry. Another key factor driving growth of the hexylene market in North America is the focus of manufacturers on customization of products as per specific applications. Hexylene glycol is also prominently used as an antifreeze agent in North America, which is bolstering its sales in the region.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-5703

Looking for More Information?

The market report on hexylene glycol published by Future Market Insights brings to the fore a pin-point analysis of the market, and offers comprehensive information with historical demand data of 2014-2018 and forecast statistics for 2019-2029. The study offers insightful information on the global hexylene glycol market based on various categories – grade (pharmaceutical and industrial), application (solvents, chemical intermediates, antifreeze, and others), and end use (construction, drugs, paints & coatings, chemicals, oil & gas, leather & textiles, and others), across seven regions. This study highlights key market players who are well-known vendors and have proven themselves as key shareholders in the global hexylene glycol market. Some of the market players included in the report are BASF SE, Solvay SA, Dow DuPont, Lonza Group, LANXESS, and Arkema, among others.

For additional information, write to the analyst at press@futuremarketinsights.com

 

Controlled and Slow Release Fertilizers Market is expected to reach US$ 10.1 Bn by the end of 2028, Says FMI Analyst

FMI presents detailed analysis and delivers key insights on the global controlled and slow release fertilizers market in its latest report titled ‘Controlled and Slow Release Fertilizers Market Forecast, Trend Analysis & Competition Tracking – Global Review 2018 to 2028’. The long-term outlook on the global controlled and slow release fertilizers market is positive with the controlled and slow release fertilizers market pegged at a value of US$ 4,791 Mn in 2018. It is expected to reach US$ 10,222.4 Mn by 2028 end, growing at a value CAGR of 9.1%. Among the segments by type, the encapsulated/coated controlled and slow release fertilizers segment is expected account for the lion’s share in terms of value and volume over the forecast period. The encapsulated/coated controlled and slow release fertilizers segment is expected to expand at a relatively higher CAGR. Among regions, Asia Pacific excluding Japan (APEJ) is anticipated to retain its dominance throughout the forecast period while growing at a rate of 11.1% from 2018 to 2028. In this report, FMI throws light on the drivers and restraints likely to impact the controlled and slow release fertilizers market during this period.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1559

Global Controlled and Slow Release Fertilizers Market Dynamics

Market insights suggest that the global controlled and slow release fertilizers market will witness high growth during the forecast period, which can be attributed to the growing population and decreasing agricultural land. Growing food consumption and increasing need for effective fertilizers are pushing the market for controlled and slow release fertilizers. The need for higher output with fewer resources is the driving the development of new technologies in the agricultural industry. With the use of conventional fertilizers, it is not possible to satisfy the growing demand for food. The use of slow and controlled release fertilizers improves the yield and saves labour. New developments such as increase in the longevity and performance of coated fertilizers are pushing the market for controlled and slow release fertilizers in agricultural as well as commercial applications. The slow release of nutrients allows fertilizers to last longer and thereby increase fertilizer performance, which is driving the demand for controlled and slow release fertilizers.

Urea reaction products also accounted for a significant share of the controlled and slow release fertilizers market; however, the increasing popularity of encapsulated coated fertilizers is expected to dominate the urea reaction product segment during the forecast period. The superior longevity of encapsulated/coated products as compared to that of urea reaction products is expected to push the growth of the encapsulated/ coated segment during the forecast.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-1559

Global Controlled and Slow Release Fertilizers Market Segmentation Analysis

The controlled and slow release fertilizers market has been segmented on the basis of application into agricultural, commercial lawn and turf and others.

  • On the basis of application, the agricultural segment is anticipated to dominate the controlled and slow release fertilizers market in terms of value and volume over the forecast period
  • The agricultural segment is also projected to grow at a relatively higher CAGR over the forecast period. It is expected to represent a total incremental opportunity of US$ 3,863 Mn between 2018 and 2028 in the global controlled and slow release fertilizers market

Global Controlled and Slow Release Fertilizers Market Regional Forecast

Regionally, APEJ accounted for over 47% of the global controlled and slow release fertilizers market value while North America accounted for the second largest share in the controlled and slow release fertilizers market. APEJ is projected to be the fastest growing region with a CAGR of 11.5% during the forecast period. Large population base and rapid population growth, improving economic conditions, change in eating habits and increasing food consumption are some of the important factors driving the demand for controlled and slow release fertilizers.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-1559

Global Controlled and Slow Release Fertilizers Market Competition Landscape

The report highlights some of the top companies operating in the global controalled and slow release fertilizers market, including Kingenta Ecological Engineering Group Co. Ltd., Israel Chemicals Ltd (ICL), Yara International ASA, Agrium Inc., Haifa Chemicals Ltd., Koch Fertilizer LLC and Aglukon Spezialduenger GmbH & Co. KG., among others.

For more information, reach out to Future Market Insights analysts at press@futuremarketinsights.com

 

Calcite Market Trends 2022 | Segmentation, Outlook, Industry Report to 2031

The growing demand for building or structure safety measures across residential, commercial and industrial sectors are key factors driving the global calcite market. According to a study by Future Market Insights (FMI), calcite sales will continue rising in response to increasing industrial applications and rising construction activities. According to FMI, the market will surpass US$ 15.14 Bn by 2021.

The demand for ground calcium carbonate or GCC calcite will remain significantly high. It is expected account for over 60% of calcite sold globally in 2021. Increasing demand for cement has resulted in significant growth in demand for calcite. Besides this, the demand from paper and pulp industry will enable the market exhibit consistent growth through the forecast period.

The global calcite market is anticipated to grow owing to the increasing investment towards residential and commercial construction. Besides this rapid urbanization will pave way for the expansion of the market. This is especially true in case of developing countries in the East. Following temporary period of sluggish growth amid COVID-19, construction sector revival is on cards for countries such as India and China.

According to the Invest India, the construction industry in India is expected to record a CAGR of 15.7% by 2022. Considering this, India will continue presenting lucrative growth opportunities for the market through the forecast period.

Download FREE Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3797

Key Takeaways of Global Calcite Market Study

  • The U.S. will account for over 80% of the North America calcite market in 2021
  • The overall value of the calcite market in the U.K. will surpass US$ 560 Mn in 2021
  •  France and Germany will remain lucrative markets for calcite backed by increasing construction activities
  • Surging investment in infrastructural development will continue fuelling demand in Japan and South Korea

“As a result of operating in a highly competitive environment, market players have been focusing on product improvement and launches as key strategies to gain competitive edge. Besides this, some of them are seeking out strategic collaborations to expand their footprint as well as product portfolio” says a lead FMI analyst.

Market Landscape Continues to Remain Moderately Fragmented

The global calcite market has been identified as a significantly fragmented market with an unorganized sector occupying major section. The Tier 1 manufacturers account for maximum share in the global market. Some leading players included in the report are Imerys S. A.,  Omya AG, J. M. Huber Corporation, Minerals Technologies Inc. and Gulshan Polyol Ltd. Tier 2 manufacturers such as ASEC Company for Mining,  Esen Mikronize A.S,  Wolkem India Ltd., Shandong CITIC Calcium Industry Co., Ltd. and Tier 3 manufacturers such as Columbia River Carbonates, Jay Minerals, Golden Lime Public Co., Ltd., Longcliffe Quarries Ltd., Vietnam CMT Joint Stock Company, Mississippi Lime Company and many regional players’ manufacturers across the globe are anticipated to create tough competitive environment on the global level.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-3797

How is Calcite Sale Affected by Applications in Construction Industry?

The growth in the construction industry is expected to have high impact on the demand for calcite in the building materials market. The demand for building materials is increasing due to the ongoing constructions activities in both commercial and residential sectors. The cement production has been increasing significantly in recent years owing to the high investment in infrastructure development activities.

This has emerged as a chief factor fuelling the demand for calcite in countries such as China, UAE, Saudi Arabia, India, and others. Thus, the increasing use of building materials and cement in these countries will significantly affect calcite market growth

Want to Know More?

Future Market Insights, in its new report, offers an unbiased analysis of the global calcite market, analysing historical demand from 2016-2020 and forecast statistics for 2021–2031. The study reveals growth projections on the calcite market on the basis of type (GCC and PCC), by size (coarse and fine), and by applications (pulp & paper, polymer & plastic, paints & coatings, cement, adhesives & sealants, and agriculture) across key regions (North America, Latin America, Europe, South Asia & Pacific, East Asia, Middle East and Africa)

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-3797

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:
Corporate Headquarter
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Website: https://www.futuremarketinsights.com